These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11183625)

  • 1. Adapting a national guideline for local use: a comparative case study in a US and an Israeli health maintenance organization.
    Shye D; Porath A; Brown JB
    J Health Serv Res Policy; 2000 Jul; 5(3):148-55. PubMed ID: 11183625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to standards of care by health maintenance organizations in Israel and the USA.
    Rosen B; Porath A; Pawlson LG; Chassin MR; Benbassat J
    Int J Qual Health Care; 2011 Feb; 23(1):15-25. PubMed ID: 21084320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care HMO clinicians' opinions about clinical practice guidelines.
    Shye D; Brown JB
    HMO Pract; 1995 Sep; 9(3):111-5. PubMed ID: 10151094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
    Guo JD; Liu GG; Christensen DB; Fu AZ
    Value Health; 2003; 6(1):18-28. PubMed ID: 12535235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing hypertension guidelines: an evolving process.
    Kotchen TA
    Am J Hypertens; 2014 Jun; 27(6):765-72. PubMed ID: 24572703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proportion of US adults potentially affected by the 2014 hypertension guideline.
    Navar-Boggan AM; Pencina MJ; Williams K; Sniderman AD; Peterson ED
    JAMA; 2014 Apr; 311(14):1424-9. PubMed ID: 24682242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transparency matters: Kaiser Permanente's National Guideline Program methodological processes.
    Davino-Ramaya C; Krause LK; Robbins CW; Harris JS; Koster M; Chan W; Tom GI
    Perm J; 2012; 16(1):55-62. PubMed ID: 22529761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tools of an evidence-based culture: implementing clinical-practice guidelines in an Israeli HMO.
    Kahan NR; Kahan E; Waitman DA; Kitai E; Chintz DP
    Acad Med; 2009 Sep; 84(9):1217-25. PubMed ID: 19707060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paradox of guideline implementation: how AHCPR's depression guideline was adapted at Kaiser Permanente Northwest Region.
    Brown JB; Shye D; McFarland B
    Jt Comm J Qual Improv; 1995 Jan; 21(1):5-21. PubMed ID: 7719400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations.
    Bennett CL; Somerfield MR; Pfister DG; Tomori C; Yakren S; Bach PB;
    J Clin Oncol; 2003 Mar; 21(5):937-41. PubMed ID: 12610197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicaid prescriber compliance with Joint National Committee VI Hypertension Treatment Guidelines.
    Clause SL; Hamilton RA
    Ann Pharmacother; 2002 Oct; 36(10):1505-11. PubMed ID: 12243597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines.
    Balu S
    Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of continuous quality improvement methods in the development and dissemination of medical practice guidelines.
    Burns LR; Denton M; Goldfein S; Warrick L; Morenz B; Sales B
    QRB Qual Rev Bull; 1992 Dec; 18(12):434-9. PubMed ID: 1287525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes.
    Andros V; Egger A; Dua U
    J Manag Care Pharm; 2006 May; 12(4):303-9. PubMed ID: 16792436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The provision of home health care services through health maintenance organizations.
    Parker M; Polich CL; Fischer LR; Pastor W; Krulewitch H; Pitt L; Olson P; Korn K
    Pride Inst J Long Term Home Health Care; 1989; 8(3):24-37. PubMed ID: 10303819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes about clinical practice guidelines in a mixed model HMO: the influence of physician and organizational characteristics.
    Salem-Schatz SR; Gottlieb LK; Karp MA; Feingold L
    HMO Pract; 1997 Sep; 11(3):111-7. PubMed ID: 10174519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do HMOs make a difference? Introduction.
    Reschovsky JD; Kemper P
    Inquiry; 1999-00 Winter; 36(4):374-7. PubMed ID: 10711312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HMO ownership on management processes and utilization outcomes.
    Ahern M; Molinari C
    Am J Manag Care; 2001 May; 7(5):489-97. PubMed ID: 11388128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managed care and the delivery of primary care to the elderly and the chronically ill.
    Wholey DR; Burns LR; Lavizzo-Mourey R
    Health Serv Res; 1998 Jun; 33(2 Pt Ii):322-53. PubMed ID: 9618674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension.
    Xu KT; Moloney M; Phillips S
    Am J Manag Care; 2003 Aug; 9(8):529-36. PubMed ID: 12921230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.